MYC and liver cancer: The essentiality of PRMT5 was further validated in another independent CRISPR screen in the NEJF6 cell line (Supplementary file 10), another MYC-driven liver cancer cell line derived from ABC-Myc mouse liver tumor (Fang et al., 2023).